Skip to main content
Important notice

Government Authentication Service

You will soon be able to access our online services using the Government Authentication Service. Get started and create your account now. Please note that the option of logging in with clicSÉQUR will be maintained for a certain period.

Avis d’autorisation de médicament de substitution, 18 mai 2022

Legal publication
Updated on

 05 July 2022

This notice was published on July 5, 2022.

Octreotide acetate replace Sandostatin.